2023 Form 5500 filing — Baxalta Incorporated And Subsidiaries Pension Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241014135737NAL0046259392001) for Baxalta Incorporated And Subsidiaries Pension Plan, reported by Takeda Pharmaceuticals U.S.A., Inc under EIN 13-4013710 and plan number 003. It reports 1,541 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241014135737NAL0046259392001
Filing year
2023
Form type
2
Plan sponsor
Takeda Pharmaceuticals U.S.A., Inc
EIN
13-4013710
Plan number
003
Location
Exton, PA
Participants
1,541
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$374,780,754
Total liabilities (EOY)
$54,594
Net assets (EOY)
$374,726,160
Employer contributions
$32,300,000
Total income / additions
$56,316,140
Benefits paid
$12,753,516
Administrative expenses
$2,652,602
Total expenses
$15,406,118
Net increase / (decrease)
$40,910,022
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
MercerNONE$625,249not reported in the loaded dataset
Towers WatsonNONE$379,249not reported in the loaded dataset
Goldman SachsNONE$217,953not reported in the loaded dataset
State Street BankNONE$70,434$0
Crowe LlpNONE$53,550not reported in the loaded dataset

Related Form 5500 pages